Here, we will give you a technical overview of the potential immunomodulatory role of Rasayana Ayurveda for cancer patients:
Cancer progression is associated with immune system suppression and diminished capacity to arrest uncontrolled cellular proliferation. Rasayana is a branch of Ayurveda encompassing various rejuvenative formulations that modulate human immunity.
Several Rasayana compounds and formulations demonstrate immunomodulating properties in preliminary studies. For example:
- Withaferin A and Withanolides from Ashwagandha (Withania Somnifera) advance anti tumor immunity by improved NK cell action, immune response subordinate cell cytotoxicity and more noteworthy IFN-γ, IL-2 creation.
- Tinospora cordifolia upregulates macrophages, neutrophils and actuates IL-4 controlled enemy of cancer reaction interceded by Th2 cells. Ayurvedic compounds like Nimbolide also stimulate macrophages.
- Embelin from Vidanga (Embelia ribes) activates dendritic cells and combining with Tinospora extracts shows increased IgG antibodies and haemolytic antibody responses.
- Certain bhasmas like Yashada Bhasma, Swarna Bhasma and Lanka Bhasma prepared from zinc, gold and red arsenic sulfides demonstrate immunoadjuvant response by stimulating B Cell & T Cell proliferation.
However, clinical evidence in cancer patients remains limited to smaller cohorts. Outcomes are generally dependent on cancer subtype, stage of progression, intervals and duration of Rasayana therapy. Suppose Guggulu formulations may interact with chemotherapy drugs. An experienced Ayurvedic practitioner’s guidance is thus recommended to develop a personalized Rasayana regimen alongside standard cancer treatment to assist endogenous immune capacity.
Key principles involve balancing Ojas, Agni and Srotas; correcting Mamsa and Rasa Dhatu distortions; and enhancing Vyadhiksamatva through immune regulation. In considered combination, Rasayana therapy may help mitigate cancer-associated immune dysfunction.
Also Read: The 10 Best Food Items That Boost Your Immune System
